These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 39265660)

  • 1. An overview of interpretability of two models of unbound fraction that are used in combination with the well-stirred model for predicting hepatic clearance of drugs.
    Poulin P
    J Pharm Sci; 2024 Nov; 113(11):3177-3190. PubMed ID: 39265660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First-in-Human Predictions of Hepatic Clearance for Drugs With the Well-Stirred Model: Comparative Assessment Between Models of Fraction Unbound Based Either on the Free Drug Hypothesis, Albumin-Facilitated Hepatic Uptake or Dynamic Binding Kinetics.
    Poulin P
    J Pharm Sci; 2024 Aug; 113(8):2641-2650. PubMed ID: 38796154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extrapolation of the Hepatic Clearance of Drugs in the Absence of Albumin In Vitro to That in the Presence of Albumin In Vivo: Comparative Assessement of 2 Extrapolation Models Based on the Albumin-Mediated Hepatic Uptake Theory and Limitations and Mechanistic Insights.
    Poulin P; Haddad S
    J Pharm Sci; 2018 Jul; 107(7):1791-1797. PubMed ID: 29567347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supplemental Analysis of the Prediction of Hepatic Clearance of Binary Mixtures of Bisphenol A and Naproxen Determined in an Isolated Perfused Rat Liver Model to Promote the Understanding of Potential Albumin-Facilitated Hepatic Uptake Mechanism.
    Poulin P; Bteich M; Haddad S
    J Pharm Sci; 2017 Nov; 106(11):3207-3214. PubMed ID: 28823401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential protein-mediated hepatic uptake: discussion on the molecular interactions between albumin and the hepatocyte cell surface and their implications for the in vitro-to-in vivo extrapolations of hepatic clearance of drugs.
    Bteich M; Poulin P; Haddad S
    Expert Opin Drug Metab Toxicol; 2019 Aug; 15(8):633-658. PubMed ID: 31274340
    [No Abstract]   [Full Text] [Related]  

  • 6. Improving Prediction of Metabolic Clearance Using Quantitative Extrapolation of Results Obtained From Human Hepatic Micropatterned Cocultures Model and by Considering the Impact of Albumin Binding.
    Da-Silva F; Boulenc X; Vermet H; Compigne P; Gerbal-Chaloin S; Daujat-Chavanieu M; Klieber S; Poulin P
    J Pharm Sci; 2018 Jul; 107(7):1957-1972. PubMed ID: 29524447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using the Dynamic Well-Stirred Model to Extrapolate Hepatic Clearance of Organic Anion-Transporting Polypeptide Transporter Substrates without Assuming Albumin-Mediated Hepatic Drug Uptake.
    Yan Z; Ma L; Hwang N; Huang J; Kenny JR; Hop CECA
    Drug Metab Dispos; 2024 May; 52(6):548-554. PubMed ID: 38604729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Introducing the Dynamic Well-Stirred Model for Predicting Hepatic Clearance and Extraction Ratio.
    Yan Z; Ma L; Carione P; Huang J; Hwang N; Kenny JR; Hop CECA
    J Pharm Sci; 2024 Apr; 113(4):1094-1112. PubMed ID: 38220087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Machine Learning Framework to Improve Rat Clearance Predictions and Inform Physiologically Based Pharmacokinetic Modeling.
    Andrews-Morger A; Reutlinger M; Parrott N; Olivares-Morales A
    Mol Pharm; 2023 Oct; 20(10):5052-5065. PubMed ID: 37713584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct determination of the ratio of unbound fraction in plasma to unbound fraction in microsomal system (fu p/fu mic) for refined prediction of phase I mediated metabolic hepatic clearance.
    Deshmukh SV; Harsch A
    J Pharmacol Toxicol Methods; 2011; 63(1):35-9. PubMed ID: 20433934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct Comparison of Total Clearance Prediction: Computational Machine Learning Model versus Bottom-Up Approach Using In Vitro Assay.
    Kosugi Y; Hosea N
    Mol Pharm; 2020 Jul; 17(7):2299-2309. PubMed ID: 32478525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of total hepatic clearance by combining metabolism, transport, and permeability data in the in vitro-in vivo extrapolation methods: emphasis on an apparent fraction unbound in liver for drugs.
    Poulin P
    J Pharm Sci; 2013 Jul; 102(7):2085-95. PubMed ID: 23613473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Assessment of Extrapolation Methods Based on the Conventional Free Drug Hypothesis and Plasma Protein-Mediated Hepatic Uptake Theory for the Hepatic Clearance Predictions of Two Drugs Extensively Bound to Both the Albumin And Alpha-1-Acid Glycoprotein.
    Bteich M; Poulin P; Haddad S
    J Pharm Sci; 2021 Mar; 110(3):1385-1391. PubMed ID: 33217427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. After 50 Years of Hepatic Clearance Models, Where Should We Go from Here? Improvements and Implications for Physiologically Based Pharmacokinetic Modeling.
    Pang KS; Lu WI; Mulder GJ
    Drug Metab Dispos; 2024 Jul; 52(8):919-931. PubMed ID: 39013583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Plasma Protein Binding in Drug Clearance Prediction: A Data Base Analysis of Published Studies and Implications for In Vitro-In Vivo Extrapolation.
    Francis LJ; Houston JB; Hallifax D
    Drug Metab Dispos; 2021 Mar; 49(3):188-201. PubMed ID: 33355201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toward a new paradigm for the efficient in vitro-in vivo extrapolation of metabolic clearance in humans from hepatocyte data.
    Poulin P; Haddad S
    J Pharm Sci; 2013 Sep; 102(9):3239-51. PubMed ID: 23494893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of hepatic clearance prediction using in vitro data: emphasis on fraction unbound in plasma and drug ionisation using a database of 107 drugs.
    Hallifax D; Houston JB
    J Pharm Sci; 2012 Aug; 101(8):2645-52. PubMed ID: 22700322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence of the need for modified well-stirred model in vitro to in vivo extrapolation.
    Chang TY; Wang HJ; Hsu SH; Chang ML; Kao LT; Pao LH
    Eur J Pharm Sci; 2022 Oct; 177():106268. PubMed ID: 35901930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Albumin and Uptake of Drugs in Cells: Additional Validation Exercises of a Recently Published Equation that Quantifies the Albumin-Facilitated Uptake Mechanism(s) in Physiologically Based Pharmacokinetic and Pharmacodynamic Modeling Research.
    Poulin P; Haddad S
    J Pharm Sci; 2015 Dec; 104(12):4448-4458. PubMed ID: 26457988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extrapolation of In Vivo Hepatic Clearance from In Vitro Uptake Clearance by Suspended Human Hepatocytes for Anionic Drugs with High Binding to Human Albumin: Improvement of In Vitro-to-In Vivo Extrapolation by Considering the "Albumin-Mediated" Hepatic Uptake Mechanism on the Basis of the "Facilitated-Dissociation Model".
    Kim SJ; Lee KR; Miyauchi S; Sugiyama Y
    Drug Metab Dispos; 2019 Feb; 47(2):94-103. PubMed ID: 30504137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.